These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31221945)

  • 21. Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia.
    Courtney A; Triwongwarant D; Chim I; Eisman S; Sinclair R
    Expert Opin Pharmacother; 2023; 24(18):1919-1922. PubMed ID: 37942878
    [No Abstract]   [Full Text] [Related]  

  • 22. A comprehensive review of biochemical factors in herbs and their constituent compounds in experimental studies on alopecia.
    Cho EC; Kim K
    J Ethnopharmacol; 2020 Aug; 258():112907. PubMed ID: 32360043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicinal Plants for the Treatment of Hair Loss and the Suggested Mechanisms.
    Shen YL; Li XQ; Pan RR; Yue W; Zhang LJ; Zhang H
    Curr Pharm Des; 2018; 24(26):3090-3100. PubMed ID: 30205796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
    Khandpur S; Suman M; Reddy BS
    J Dermatol; 2002 Aug; 29(8):489-98. PubMed ID: 12227482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of minoxidil on hair growth in androgenic alopecia in women].
    Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review.
    Ashique S; Sandhu NK; Haque SN; Koley K
    Nat Prod Bioprospect; 2020 Dec; 10(6):345-365. PubMed ID: 33011954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herbal Medicines as Adjuvants for the Treatment of Chemotherapy-Induced Diarrhea.
    Zheng Z; Srinual S; Chen J; Li L; Du T; Hu M; Sun R; Gao S
    Curr Drug Metab; 2023; 24(6):422-433. PubMed ID: 37592799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials.
    Bajoria PS; Dave PA; Rohit RK; Tibrewal C; Modi NS; Gandhi SK; Patel P
    Cureus; 2023 Jul; 15(7):e42768. PubMed ID: 37663989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescribing Habits for Androgenic Alopecia among Dermatologists in Spain in 2019-2020: A Cross-Sectional Study.
    Pindado-Ortega C; Saceda-Corralo D; Fernández-Nieto D; Jiménez-Cauhé J; Ortega-Quijano D; Moreno-Arrones ÓM; Vañó-Galván S
    Skin Appendage Disord; 2020 Sep; 6(5):283-286. PubMed ID: 33088813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Comparison of QR 678
    Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
    J Cosmet Dermatol; 2021 Jun; 20(6):1763-1765. PubMed ID: 33864424
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.
    Meidan VM; Touitou E
    Drugs; 2001; 61(1):53-69. PubMed ID: 11217871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical treatments for balding in men.
    Scow DT; Nolte RS; Shaughnessy AF
    Am Fam Physician; 1999 Apr; 59(8):2189-94, 2196. PubMed ID: 10221304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Review on Herbal Medicine: Emphasis on Current Therapy and Role of Phytoconstituents for Cancer Treatment.
    Sharma AN; Dewangan HK; Upadhyay PK
    Chem Biodivers; 2024 Mar; 21(3):e202301468. PubMed ID: 38206170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are hand preference and sexual orientation possible predicting factors for finasteride adverse effects in male androgenic alopecia?
    Motofei IG; Rowland DL; Georgescu SR; Tampa M; Baleanu BC; Paunica S
    Exp Dermatol; 2016 Jul; 25(7):557-8. PubMed ID: 26990657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
    Gentile P; Garcovich S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level laser therapy for the treatment of androgenic alopecia: a review.
    Darwin E; Heyes A; Hirt PA; Wikramanayake TC; Jimenez JJ
    Lasers Med Sci; 2018 Feb; 33(2):425-434. PubMed ID: 29270707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the effect of autologous platelet-rich plasma on androgenic alopecia.
    Makki M; Younes AH; Salah I
    J Cosmet Laser Ther; 2020 Jul; 22(4-5):190-194. PubMed ID: 33012215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.